Comparisons between two receptor assays for 1,25-dihydroxyvitamin D.

Area of Science:

• Endocrinology
• Biochemistry
• Assay Development

Background:

• 1,25(OH)2D is a crucial vitamin D metabolite regulating calcium and phosphate homeostasis.
• Existing competitive protein binding assays (CPBA) for 1,25(OH)2D often utilize receptors from animal sources, with chick intestinal receptor being common.
• Assay sensitivity, specificity, and precision are critical for accurate clinical and research measurements of 1,25(OH)2D.

Purpose of the Study:

• To develop and validate a novel CPBA for 1,25(OH)2D using a calf thymus receptor.
• To compare the performance characteristics (sensitivity, specificity, precision) of the thymus receptor assay against a conventional chick intestinal receptor assay.
• To evaluate the utility of the new assay in measuring serum 1,25(OH)2D levels across different physiological states and in response to vitamin D supplementation.

Main Methods:

• Development of a competitive protein binding assay (CPBA) utilizing the 1,25(OH)2D receptor isolated from calf thymus.
• Comparative analysis of the calf thymus receptor assay against a CPBA employing the 1,25(OH)2D receptor from rachitic chick intestine.
• Assessment of assay sensitivity, specificity, and precision, including evaluation of binding affinity for 1,25(OH)2D2 and 1,25(OH)2D3.
• Measurement of mean serum 1,25(OH)2D levels in various subject groups (normal, post-menopausal, pregnant, chronic renal failure) using both assay systems.
• Evaluation of the impact of vitamin D2 or D3 supplementation on serum 1,25(OH)2D levels in post-menopausal women.

Main Results:

• The calf thymus receptor assay demonstrated superior sensitivity, specificity, and precision compared to the chick intestinal receptor assay.
• The thymus receptor assay exhibited equal binding affinity for both 1,25(OH)2D2 and 1,25(OH)2D3.
• In contrast, the chick intestinal receptor assay showed 1,25(OH)2D2 to be 1.1 times less potent than 1,25(OH)2D3.
• Mean serum 1,25(OH)2D values obtained from both assay systems did not significantly differ across the studied populations.
• Serum 1,25(OH)2D levels remained unchanged in post-menopausal women after 8 weeks of vitamin D2 or D3 supplementation, as measured by both assays.

Conclusions:

• The calf thymus receptor-based CPBA is a highly sensitive, specific, and precise method for quantifying 1,25(OH)2D.
• The equal affinity for both vitamin D2 and D3 analogues makes the thymus receptor assay a robust and reliable alternative to the chick intestinal receptor assay.
• This validated assay provides a valuable tool for accurate 1,25(OH)2D measurements in clinical and research settings.